Reuters logo
8 months ago
BRIEF-Catalyst Biosciences entered into agreement with Wyeth Llc
December 14, 2016 / 9:57 PM / 8 months ago

BRIEF-Catalyst Biosciences entered into agreement with Wyeth Llc

Dec 14 (Reuters) - Catalyst Biosciences Inc :

* Catalyst Biosciences -pursuant to agreement, wyeth has granted co exclusive license to wyeth's proprietary rights applying to factor viia variants, cb 813a and cb 813d

* On december 8, 2016, co entered into definitive agreement with wyeth llc, a wholly-owned subsidiary of pfizer inc

* Catalyst Biosciences- in connection with license granted by wyeth to co,co agreed to make contingent cash payments to wyeth in of about $17.5 million Source text bit.ly/2hwXm2R Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below